Resveratrol blocks retrotransposition of LINE-1 through PPAR α and sirtuin-6.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 05 2022
Historique:
received: 31 08 2021
accepted: 26 04 2022
entrez: 13 5 2022
pubmed: 14 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

The retroelement long interspersed element-1 (LINE-1 or L1) comprises about 17% of the human genome. L1 retrotransposition is known to cause genomic instability and related disorders, and resveratrol suppresses this retrotransposition; however, the underlying mechanism is still not elucidated. Recent observations showed that low-molecular-weight compounds might induce L1 retrotransposition through unknown mechanisms. This study aimed to determine polyphenol resveratrol (RV)'s effect on L1-RTP (retrotransposition) in somatic cells. Surprisingly, RV completely blocked L1-RTP. Experiments using the PPARα inhibitor GW6471 or siRNA-mediated PPARα depletion showed that RV-mediated L1-RTP's inhibition depended on peroxisome proliferator-activated receptor α (PPARα). We demonstrated that RV inhibits p38 and cAMP response element binding protein phosphorylation, which are involved in MAPK signaling, and the L1-ORF1 protein's chromatin recruitment. Furthermore, RV increased the expression of sirtuin-6 (SIRT6), which inhibited the activation of L1. The sirtuins family, SIRT1, SIRT6, and SIRT7, but not SIRT3, are involved in RV-mediated inhibition of L1-RTP. Overall, our findings suggest that RV directly modulates PPARα-mediated L1-RTP in somatic cells and that MAPK signaling interacts with SIRT6 closely and may play a role in preventing human diseases such as cancer.

Identifiants

pubmed: 35546166
doi: 10.1038/s41598-022-11761-0
pii: 10.1038/s41598-022-11761-0
pmc: PMC9095727
doi:

Substances chimiques

PPAR alpha 0
Retroelements 0
SIRT6 protein, human EC 3.5.1.-
Sirtuin 1 EC 3.5.1.-
Sirtuins EC 3.5.1.-
Resveratrol Q369O8926L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7772

Informations de copyright

© 2022. The Author(s).

Références

Toxicol Sci. 2005 Jun;85(2):935-43
pubmed: 15788723
Nucleic Acids Res. 2019 Sep 5;47(15):7870-7885
pubmed: 31226208
Nat Neurosci. 2013 May;16(5):529-31
pubmed: 23563579
J Biol Chem. 2014 Sep 12;289(37):25476-85
pubmed: 25053411
Mol Cell Biochem. 2016 Jan;411(1-2):143-50
pubmed: 26423427
Cancer Res. 1992 Feb 1;52(3):643-5
pubmed: 1310068
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4298-303
pubmed: 25831499
Oncogene. 2013 Oct 10;32(41):4903-12
pubmed: 23208499
Life Sci. 2002 Jun 28;71(6):655-65
pubmed: 12072154
Int J Mol Sci. 2018 Jul 20;19(7):
pubmed: 30037017
Cell Metab. 2019 Apr 2;29(4):871-885.e5
pubmed: 30853213
Chem Res Toxicol. 2007 Jan;20(1):88-94
pubmed: 17226930
J Agric Food Chem. 2002 May 22;50(11):3337-40
pubmed: 12010007
Science. 1991 Dec 20;254(5039):1808-10
pubmed: 1722352
Cancer Sci. 2011 Nov;102(11):2000-6
pubmed: 21827582
Nutr Cancer. 2012;64(4):493-502
pubmed: 22482424
J Biol Chem. 2018 Dec 7;293(49):19025-19037
pubmed: 30327428
Genes Dev. 2009 Jun 1;23(11):1303-12
pubmed: 19487571
Science. 2011 Feb 4;331(6017):593-6
pubmed: 21233348
Nature. 1988 Mar 10;332(6160):164-6
pubmed: 2831458
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11277-11282
pubmed: 27621458
Cell. 1996 Nov 29;87(5):917-27
pubmed: 8945518
J Mol Biol. 2006 Apr 14;357(5):1383-93
pubmed: 16490214
PLoS One. 2013 Sep 11;8(9):e74629
pubmed: 24040300
Nature. 1988 May 5;333(6168):87-90
pubmed: 2834650
Nat Commun. 2014 Sep 23;5:5011
pubmed: 25247314
Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14572-9
pubmed: 15310846
Blood. 2016 Mar 3;127(9):1138-50
pubmed: 26675349
Cell. 2008 Oct 3;135(1):23-35
pubmed: 18854152
BMC Biol. 2011 Sep 29;9:62
pubmed: 21958341
Mob Genet Elements. 2015 Dec 4;6(1):e1119927
pubmed: 27066302
Cell. 1996 Nov 29;87(5):905-16
pubmed: 8945517
Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):679-88
pubmed: 19822084
Hum Mutat. 2007 Jun;28(6):527-39
pubmed: 17309057
Front Chem. 2016 Jun 28;4:28
pubmed: 27446907
Elife. 2018 Jan 08;7:
pubmed: 29309036
Mol Cell Biol. 2007 Sep;27(18):6469-83
pubmed: 17562864
Nature. 2011 Oct 30;479(7374):534-7
pubmed: 22037309
Cell. 2002 Aug 9;110(3):315-25
pubmed: 12176319
Retrovirology. 2013 Aug 05;10:83
pubmed: 23915234
Nature. 2019 Feb;566(7742):73-78
pubmed: 30728521
J Cell Mol Med. 2015 Oct;19(10):2324-8
pubmed: 26177159
Circulation. 2002 Sep 24;106(13):1652-8
pubmed: 12270858
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18487-92
pubmed: 20852066
Science. 2004 Mar 12;303(5664):1626-32
pubmed: 15016989
Nature. 2015 Mar 19;519(7543):370-3
pubmed: 25533949
In Vivo. 2016 Mar-Apr;30(2):113-8
pubmed: 26912821
Mob DNA. 2016 Aug 11;7:16
pubmed: 27525044
EMBO J. 1996 Feb 1;15(3):630-9
pubmed: 8599946
Brain Res. 2002 Dec 27;958(2):439-47
pubmed: 12470882
Sci Rep. 2016 Apr 21;6:24744
pubmed: 27098390
PLoS One. 2015 Mar 23;10(3):e0120865
pubmed: 25798826
Front Microbiol. 2012 May 31;3:191
pubmed: 22666219

Auteurs

Noriyuki Okudaira (N)

Department of Biochemistry, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan. nokudaira@med.teikyo-u.ac.jp.

Yukihito Ishizaka (Y)

Department of Intractable Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.

Mimi Tamamori-Adachi (M)

Department of Biochemistry, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH